Evidence map›Paper›PMID 33931961›Full record

ArticleClinical and translational medicine2021

Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19.

Rita Valenzuela, Maria A Pedrosa, Pablo Garrido-Gil, Carmen M Labandeira, Gemma Navarro, Rafael Franco, Ana I Rodriguez-Perez, Jose L Labandeira-Garcia

Open access · goldAbstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. ACE2: the node connecting the lung cancer and COVID-19.American journal of cancer research · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Structural biology of SARS-CoV-2: open the door for novel therapies.Signal transduction and targeted therapy · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rita ValenzuelaResearch Center for Molecular Medicine and Chronic diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Maria A PedrosaResearch Center for Molecular Medicine and Chronic diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Pablo Garrido-GilResearch Center for Molecular Medicine and Chronic diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Carmen M LabandeiraResearch Center for Molecular Medicine and Chronic diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Gemma NavarroNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Rafael FrancoNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Ana I Rodriguez-PerezResearch Center for Molecular Medicine and Chronic diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Jose L Labandeira-GarciaResearch Center for Molecular Medicine and Chronic diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.ORCID 0000-0002-8243-9791
Universidade de Santiago de Compostela · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ES

Funding

Axencia Galega de Innovación IN845D 2020/20Galician Government ED431C 2018/10Galician Government ED431G/05Galician Government XUGARegional European Development FundSpanish Ministry of Economy and Competitiveness RTI2018-094204-B-I00Spanish Ministry of Economy and Competitiveness RTI2018-098830-B-I00Spanish Ministry of Health CIBERNEDSpanish Ministry of Health PI17/00828Spanish Ministry of Health RD16/0011/0016
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsCOVID-19Disease Models, AnimalHumansIbuprofenLungRatsRenin-Angiotensin SystemSpike Glycoprotein, CoronavirusAce2 protein, ratAngiotensin-Converting Enzyme 2IbuprofenSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID33931961
PMCPMC8019581
OpenAlexW3150966661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.